Brain-type natriuretic peptide (BNP) is a useful biomarker not only for heart failure but across a range of cardiovascular diseases, with diagnostic and prognostic value in multiple conditions.
Beyond heart failureBNP provides diagnostic and prognostic value across 5+ cardiovascular conditions, not just heart failure
What the researchers found
BNP is a versatile cardiovascular biomarker with diagnostic and prognostic value across heart failure, coronary disease, atrial fibrillation, pulmonary hypertension, and cardiac surgery.
Why it matters
A single blood test that provides information across multiple heart conditions is extremely valuable. Understanding BNP's broader utility helps clinicians use this peptide biomarker more effectively.
The numbers in context
175 chimpanzees in cross-sectional analysis. 76 chimpanzees followed longitudinally. Study period: July 2010 to October 2024 (14+ years).
How the study worked
Review of BNP diagnostic and prognostic utility across multiple cardiovascular disease categories.
Who was studied
Captive chimpanzees (Pan troglodytes) — 175 cross-sectional, 76 longitudinal
What this study cannot tell us
BNP levels are affected by age, BMI, kidney function, and some medications. No single cutoff value works for all conditions. Combining BNP with clinical assessment is essential.
How to read the evidence
Strong evidence: comprehensive review of an established biomarker with extensive clinical validation across multiple conditions.
When this study was published
Published in 2025. Updated review of BNP clinical utility across cardiovascular disease.
The bigger picture
Natriuretic peptides are the heart's own stress hormones. BNP and NT-proBNP have become standard cardiovascular biomarkers alongside troponin. Understanding their full range of applications makes them central tools in cardiovascular medicine.
Questions still open
- Should BNP be measured routinely in all cardiovascular patients?
- How do obesity-related BNP changes affect interpretation in GLP-1 drug users?
- Could serial BNP monitoring guide cardiovascular treatment intensity?
Common questions
What does a high BNP level mean?
Should I ask my doctor about BNP testing?
Read the original research
Brain-type natriuretic peptide is a useful biomarker of cardiovascular disease and predictor of cardiac-related mortality in chimpanzees (Pan troglodytes).
American journal of veterinary research, 86(3)
Citation
Achorn, Angela M; Hodo, Carolyn L; Hensel, Martha E; Magden, Elizabeth R; Buchl, Stephanie J; Jones, Charla L; Piatt, Elizabeth A; Hopkins, William D. (2025). Brain-type natriuretic peptide is a useful biomarker of cardiovascular disease and predictor of cardiac-related mortality in chimpanzees (Pan troglodytes).. American journal of veterinary research, 86(3). https://doi.org/10.2460/ajvr.24.09.0287